Clinical Trial Update: N-acetylcysteine Plus Naltrexone for the Treatment of Alcohol Dependence [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a combination of N-acetylcysteine and naltrexone in alcohol dependence has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholism

Drugs mentioned

• N-acetylcysteine (NAC) + naltrexone (N-acetylcysteine; naltrexone)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Alcoholism | Phase 2 | Status: COMPLETED | Results posted: 2017-03-28